NOX 4.17% 6.9¢ noxopharm limited

large sales, page-7

  1. 355 Posts.
    lightbulb Created with Sketch. 58
    Exactly there’s been no news. There is going to be short term fluctuations in the SP of a small cap biotech, indeed and overs.

    The company is cashed up, has laid out a clear 1-2 year plan, unless they don’t deliver on the plan in terms of results not sure why anyone would consider selling.

    Stay long
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.